Vivotif

Vivotif is an oral typhoid vaccine containing the live, attenuated Salmonella Typhi strain Ty21a. It helps protect against typhoid fever caused by Salmonella Typhi bacteria. This vaccine is taken as capsules for oral use. Suitable for travelers to high-risk areas.

Vivotif is used to prevent typhoid fever, a bacterial infection spread through contaminated food and water. It is recommended for travelers visiting regions where typhoid is common. The vaccine works by stimulating the body's immune response to the bacteria. It does not treat active infections but helps reduce the risk of illness.

After taking Vivotif, the body may develop immunity to Salmonella Typhi over time. Some users may experience mild digestive discomfort or mild flu-like symptoms. These effects are generally temporary and indicate the vaccine is working. Most people tolerate the vaccine well with no noticeable reactions.

Vivotif should be stored in a cool, dry place away from direct sunlight. Keep the vaccine out of reach of children. Do not use if the packaging is damaged or the capsules are broken. Consult a healthcare provider before use if you have a weakened immune system or a fever.

Vivotif may interact with antibiotics or other live vaccines. Avoid taking antibiotics for at least 72 hours before and after vaccination, as they may reduce effectiveness. Some medications, such as chloroquine or mefloquine, may also affect the vaccine's performance. Always inform your healthcare provider about any medications you are taking.